Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Moazedi-Fuerst, FC; Kielhauser, SM; Hermann, J; Meilinger, M; Demel, U; Stradner, MH; Graninger, WB.
Decrease in autoantibody titres during long-term treatment of scleroderma with rituximab: a promising surveillance marker of therapy?
Scand J Rheumatol. 2015; 44(6):519-520
Doi: 10.3109/03009742.2015.1069888
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Moazedi-Fürst Florentine
- Co-authors Med Uni Graz
- Demel Ulrike
- Graninger Winfried
- Hermann Josef
- Kielhauser Sonja
- Meilinger Michael
- Stradner Martin Helmut
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Antibodies, Antinuclear - blood
- Antibodies, Antinuclear - immunology
- Antirheumatic Agents - therapeutic use
- Autoantibodies - blood
- Autoantibodies - immunology
- Biomarkers - blood
- DNA Topoisomerases, Type I - blood
- DNA Topoisomerases, Type I - immunology
- Dose-Response Relationship, Drug -
- Humans -
- Immunologic Surveillance -
- Rituximab - therapeutic use
- Scleroderma, Diffuse - blood
- Scleroderma, Diffuse - drug therapy
- Scleroderma, Diffuse - immunology
- Sensitivity and Specificity -
- Time Factors -
- Treatment Outcome -